Drug Database
Back to search

Poland· PL-100422761

Pregnyl

A chorionic gonadotrophin product containing gonadotropinum chorionicum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC G03GA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPregnylATCG03GA01REGISTER NO.PL-100422761PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gonadotropinum chorionicumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chorionic gonadotrophin is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA01 (chorionic gonadotrophin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search chorionic gonadotrophin products by name

Chorionic gonadotrophin · ATC G03GA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Gonadotropinum chorionicum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
G03GA01
ATC class
Chorionic gonadotrophin
Defined daily dose
7.5 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991408374
  • gtin
    05909991408381

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for chorionic gonadotrophin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chorionic gonadotrophin against other medicinesHow interaction checks work

Chorionic gonadotrophin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chorionic gonadotrophin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chorionic gonadotrophin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Menopur, Menopur Neo
  • Belgium · Menopur, Menotrophin Ferring
  • Bulgaria · Menopur, Менопур
  • Cyprus · Menopur
  • Czechia · Menopur, Menotrophin Ferring-Léciva
  • Germany · Brevactid, Menogon Hp
  • Denmark · Menopur
  • Estonia · Menopur
  • Spain · Menopur
  • Finland · Menopur
  • France · Menopur
  • United Kingdom (Northern Ireland) · Menopur
  • Greece · Menopur
  • Croatia · Menopur
  • Hungary · Menopur
  • Ireland · Menopur, Menotrophin
  • Iceland · Menopur
  • Italy · Meropur
  • Lithuania · Menopur
  • Luxembourg · Menopur, Menotrophin Ferring
  • Latvia · Menopur
  • Malta · Menopur
  • Netherlands · Menopur
  • Norway · Menopur
  • Portugal · Menopur
  • Romania · Menopur
  • Sweden · Menopur
  • Slovenia · Menopur
  • Slovakia · Menopur, Menotrophin Ferring

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c8f8a574-dafe-4953-922a-6bf65e7a9124
GET /v1/drugs/c8f8a574-dafe-4953-922a-6bf65e7a9124?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "5000 j.m.",
  "packaging": "05909991408374 ¦ Rp ¦ 133265\n1 fiol.  proszku ¦ 1 fiol. 1 ml rozp.\n05909991408381 ¦ Rp ¦ 133266\n3 fiol.  proszku ¦ 3 fiol. 1 ml rozp.",
  "substance": null,
  "common_name": "Gonadotropinum chorionicum",
  "pl_product_id": "100422761",
  "pozwolenie_nr": "241/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-06-27"
}
API referenceMCP serverPlans

See everything about chorionic gonadotrophin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console